Parallel Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $105K | Buy |
377
+15
| +4% | +$4.32K | ﹤0.01% | 1554 |
|
|
2025
Q4 | $110K | Buy |
362
+5
| +1% | +$1.56K | ﹤0.01% | 1418 |
|
|
2025
Q3 | $100K | Sell |
357
-16
| -4% | -$4.35K | ﹤0.01% | 1420 |
|
|
2025
Q2 | $90K | Buy |
373
+27
| +8% | +$6.38K | ﹤0.01% | 1409 |
|
|
2025
Q1 | $84.3K | Sell |
346
-51
| -13% | -$15.3K | ﹤0.01% | 1358 |
|
|
2024
Q4 | $130K | Sell |
397
-52
| -12% | -$17.6K | ﹤0.01% | 1138 |
|
|
2024
Q3 | $150K | Buy |
449
+47
| +12% | +$14.9K | ﹤0.01% | 1047 |
|
|
2024
Q2 | $110K | Buy |
402
+234
| +139% | +$68.1K | ﹤0.01% | 1137 |
|
|
2024
Q1 | $58.1K | Sell |
168
-3
| -2% | -$987 | ﹤0.01% | 1421 |
|
|
2023
Q4 | $55.2K | Buy |
171
+46
| +37% | +$14.4K | ﹤0.01% | 1391 |
|
|
2023
Q3 | $44.8K | Buy |
125
+13
| +12% | +$5.02K | ﹤0.01% | 1444 |
|
|
2023
Q2 | $42.5K | Sell |
112
-11
| -9% | -$4.48K | ﹤0.01% | 1483 |
|
|
2023
Q1 | $58.9K | Sell |
123
-2
| -2% | -$936 | ﹤0.01% | 1301 |
|
|
2022
Q4 | $52.6K | Sell |
125
-71
| -36% | -$28.7K | ﹤0.01% | 1257 |
|
|
2022
Q3 | $82K | Sell |
196
-173
| -47% | -$86.3K | ﹤0.01% | 1044 |
|
|
2022
Q2 | $183K | Sell |
369
-166
| -31% | -$86.5K | 0.01% | 717 |
|
|
2022
Q1 | $310K | Sell |
535
-185
| -26% | -$112K | 0.01% | 568 |
|
|
2021
Q4 | $544K | Buy |
720
+53
| +8% | +$39.7K | 0.02% | 417 |
|
|
2021
Q3 | $498K | Buy |
667
+68
| +11% | +$50.9K | 0.02% | 406 |
|
|
2021
Q2 | $386K | Sell |
599
-10
| -2% | -$6.09K | 0.02% | 458 |
|
|
2021
Q1 | $348K | Sell |
609
-10
| -2% | -$5.92K | 0.02% | 454 |
|
|
2020
Q4 | $361K | Buy |
619
+54
| +10% | +$30.8K | 0.02% | 401 |
|
|
2020
Q3 | $291K | Buy |
565
+50
| +10% | +$25.3K | 0.02% | 435 |
|
|
2020
Q2 | $232K | Buy |
515
+93
| +22% | +$41K | 0.02% | 491 |
|
|
2020
Q1 | $147K | Buy |
422
+244
| +137% | +$89.7K | 0.01% | 554 |
|
|
2019
Q4 | $66K | Hold |
178
| – | – | 0.01% | 943 |
|
|
2019
Q3 | $59K | Sell |
178
-13
| -7% | -$4.24K | 0.01% | 911 |
|
|
2019
Q2 | $60K | Hold |
191
| – | – | 0.01% | 841 |
|
|
2019
Q1 | $58K | Buy |
191
+12
| +7% | +$3.24K | 0.01% | 805 |
|
|
2018
Q4 | $41K | Buy |
179
+12
| +7% | +$3.22K | 0.01% | 827 |
|
|
2018
Q3 | $52K | Hold |
167
| – | – | 0.01% | 801 |
|
|
2018
Q2 | $48K | Hold |
167
| – | – | 0.01% | 739 |
|
|
2018
Q1 | $42K | Hold |
167
| – | – | 0.01% | 757 |
|
|
2017
Q4 | $40K | Hold |
167
| – | – | 0.01% | 771 |
|
|
2017
Q3 | $42K | Sell |
167
-17
| -9% | -$3.83K | 0.01% | 741 |
|
|
2017
Q2 | $43K | Buy |
184
+45
| +32% | +$9.81K | 0.01% | 730 |
|
|
2017
Q1 | $31K | Sell |
139
-28
| -17% | -$5.39K | 0.01% | 792 |
|
|
2016
Q4 | $30K | Buy |
+167
| New | +$28.5K | 0.01% | 726 |
|
Other funds holding BIO
VCM
VPM
AI
